Clinical trials using genetic analysis are forecasted to be 3.5 months quicker in 2025 

For biopharmaceutical developers, optimizing R&D investment in new technologies is an essential way to gain and sustain a competitive edge. Clinical trials present a tremendous opportunity to leverage advanced genetics technologies and practices to improve efficiency and reduce costs. 

Stay ahead of the curve and download the report to learn: 

  • How genetic analysis is enabling more rapid and efficient clinical trials 
  • How integration of genetic analysis technologies is evolving in the pharma and biotech spaces 
  • How companies around the world are deploying genetic analysis to gain competitive advantage